Streetbeat News

Price Targets

SNTI

Chardan Capital analyst Geulah Livshits has reiterated a 'Buy' rating on Senti Biosciences (NASDAQ:SNTI) and maintained a $6 price target.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 8:25 am

VLN

Chardan Capital analyst Brian Dobson has maintained a 'Buy' rating on Valens Semiconductor (NYSE:VLN) but lowered the price target from $9 to $5.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 8:22 am

BILL

Piper Sandler analyst Brent Bracelin has reiterated an Overweight rating on BILL Holdings (NYSE:BILL) and maintained a price target of $165.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 8:21 am

KELYA

Barrington Research analyst Kevin Steinke has maintained an 'Outperform' rating on Kelly Services (NASDAQ:KELYA) and raised the price target from $25 to $26.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 8:18 am

LQDT

Barrington Research analyst Gary Prestopino has maintained an 'Outperform' rating on Liquidity Services (NASDAQ:LQDT) and raised the price target from $20 to $27.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 8:17 am

MNDY

Keybanc analyst Jason Celino maintains an Overweight rating on Monday.Com (NASDAQ:MNDY) and raises the price target from $200 to $211.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 8:15 am

TSHA

Needham analyst Gil Blum maintains a 'Buy' rating on Taysha Gene Therapies (NASDAQ:TSHA) but lowers the price target from $6 to $5.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 8:13 am

GMDA

Needham analyst Gil Blum has reiterated a 'Buy' rating on Gamida Cell (NASDAQ:GMDA) and maintained a price target of $6.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 8:13 am

FATH

Needham analyst James Ricchiuti has reiterated a 'Buy' rating on Fathom Digital Mfg (NYSE:FATH) and maintained a price target of $1.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 8:12 am

ODD

Keybanc analyst Scott Schoenhaus has initiated coverage on ODDITY Tech (NASDAQ:ODD) with an Overweight rating and a price target of $60.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 8:10 am